4-((2,6-Dibromo-4-(3,3,6,6-tetramethyl-1,8-dioxo-1,2,3,4,5,6,7,8,9,10-decahydroacridin-9-yl)phenoxy)methyl)benzoicacid

ID: ALA4170095

Cas Number: 364610-26-4

PubChem CID: 585015

Max Phase: Preclinical

Molecular Formula: C14H11BrO3

Molecular Weight: 307.14

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1ccc(COc2ccccc2Br)cc1

Standard InChI:  InChI=1S/C14H11BrO3/c15-12-3-1-2-4-13(12)18-9-10-5-7-11(8-6-10)14(16)17/h1-8H,9H2,(H,16,17)

Standard InChI Key:  RSOSIENOPSGTLO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
   13.9032  -16.6492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9021  -17.4687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6101  -17.8777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3198  -17.4683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3169  -16.6456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6083  -16.2403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1940  -17.8768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4867  -17.4676    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1934  -18.6940    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.0231  -16.2343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0200  -15.4172    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7262  -15.0059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4307  -15.4154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1364  -15.0048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1338  -14.1867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4195  -13.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7168  -14.1939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4309  -16.2325    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  7  8  2  0
  7  9  1  0
  5 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 13 18  1  0
M  END

Alternative Forms

Associated Targets(non-human)

GCN5 Histone acetyltransferase GCN5 (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 307.14Molecular Weight (Monoisotopic): 305.9892AlogP: 3.73#Rotatable Bonds: 4
Polar Surface Area: 46.53Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.06CX Basic pKa: CX LogP: 3.97CX LogD: 0.84
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.94Np Likeness Score: -0.56

References

1. Xiong H, Han J, Wang J, Lu W, Wang C, Chen Y, Fulin Lian, Zhang N, Liu YC, Zhang C, Ding H, Jiang H, Lu W, Luo C, Zhou B..  (2018)  Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening.,  151  [PMID:29665527] [10.1016/j.ejmech.2018.02.005]

Source